BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37916833)

  • 1. Adenovirus E1B-55K controls SUMO-dependent degradation of antiviral cellular restriction factors.
    Ip W-H; Tatham MH; Krohne S; Gruhne J; Melling M; Meyer T; Gornott B; Bertzbach LD; Hay RT; Rodriguez E; Dobner T
    J Virol; 2023 Nov; 97(11):e0079123. PubMed ID: 37916833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.
    Müncheberg S; Hay RT; Ip WH; Meyer T; Weiß C; Brenke J; Masser S; Hadian K; Dobner T; Schreiner S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29695423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-Protein Interactions Facilitate E4orf6-Dependent Regulation of E1B-55K SUMOylation in HAdV-C5 Infection.
    Fiedler M; Ip WH; Hofmann-Sieber H; Wilkens B; Nkrumah FK; Zhang W; Ehrhardt A; Bertzbach LD; Dobner T
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved E1B-55K SUMOylation in Different Human Adenovirus Species Is a Potent Regulator of Intracellular Localization.
    Kolbe V; Ip WH; Kieweg-Thompson L; Lang J; Gruhne J; Meyer T; Wilkens B; Schie M; Thünauer R; Schreiner S; Bertzbach LD; Rodríguez E; Dobner T
    J Virol; 2022 Feb; 96(3):e0083821. PubMed ID: 34787461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KAP1 Is a Host Restriction Factor That Promotes Human Adenovirus E1B-55K SUMO Modification.
    Bürck C; Mund A; Berscheminski J; Kieweg L; Müncheberg S; Dobner T; Schreiner S
    J Virol; 2016 Jan; 90(2):930-46. PubMed ID: 26537675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.
    Higginbotham JM; O'Shea CC
    J Virol; 2015 Oct; 89(20):10260-72. PubMed ID: 26223632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus E1B 55-Kilodalton Protein Targets SMARCAL1 for Degradation during Infection and Modulates Cellular DNA Replication.
    Nazeer R; Qashqari FSI; Albalawi AS; Piberger AL; Tilotta MT; Read ML; Hu S; Davis S; McCabe CJ; Petermann E; Turnell AS
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adenovirus E1B-55K oncoprotein induces SUMO modification of p53.
    Muller S; Dobner T
    Cell Cycle; 2008 Mar; 7(6):754-8. PubMed ID: 18461721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
    Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus type 5 early region 1B 55K oncoprotein-dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells.
    Schreiner S; Wimmer P; Groitl P; Chen SY; Blanchette P; Branton PE; Dobner T
    J Virol; 2011 Sep; 85(17):8752-65. PubMed ID: 21697482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apobec3A Deamination Functions Are Involved in Antagonizing Efficient Human Adenovirus Replication and Gene Expression.
    Göttig L; Weiß C; Stubbe M; Hanrieder L; Hofmann S; Grodziecki A; Stadler D; Carpentier A; Protzer U; Schreiner S
    mBio; 2023 Jun; 14(3):e0347822. PubMed ID: 37154747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation.
    Baker A; Rohleder KJ; Hanakahi LA; Ketner G
    J Virol; 2007 Jul; 81(13):7034-40. PubMed ID: 17459921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E1B-55K Is a Phosphorylation-Dependent Transcriptional and Posttranscriptional Regulator of Viral Gene Expression in Human Adenovirus C5 Infection.
    Hidalgo P; Garcés Y; Mundo E; López RE; Bertzbach LD; Dobner T; González RA
    J Virol; 2022 Mar; 96(5):e0206221. PubMed ID: 35019711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications.
    Sohn SY; Hearing P
    mBio; 2019 Feb; 10(1):. PubMed ID: 30808699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes.
    Ip WH; Wilkens B; Solomatina A; Martin J; Melling M; Hidalgo P; Bertzbach LD; Speiseder T; Dobner T
    Viruses; 2021 May; 13(6):. PubMed ID: 34071532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of protein expression during wild-type, and E1B-55k-deletion, adenovirus infection using quantitative time-course proteomics.
    Fu YR; Turnell AS; Davis S; Heesom KJ; Evans VC; Matthews DA
    J Gen Virol; 2017 Jun; 98(6):1377-1388. PubMed ID: 28631589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML.
    Wimmer P; Schreiner S; Everett RD; Sirma H; Groitl P; Dobner T
    Oncogene; 2010 Oct; 29(40):5511-22. PubMed ID: 20639899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biology of the adenovirus E1B 55K protein.
    Hidalgo P; Ip WH; Dobner T; Gonzalez RA
    FEBS Lett; 2019 Dec; 593(24):3504-3517. PubMed ID: 31769868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Adenovirus E1B-55K Interaction Partners through a Common Binding Motif.
    Chalabi Hagkarim N; Ip WH; Bertzbach LD; Abualfaraj T; Dobner T; Molloy DP; Stewart GS; Grand RJ
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus regulates sumoylation of Mre11-Rad50-Nbs1 components through a paralog-specific mechanism.
    Sohn SY; Hearing P
    J Virol; 2012 Sep; 86(18):9656-65. PubMed ID: 22740413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.